139 related articles for article (PubMed ID: 11854917)
21. Transfection of tubule cells with Fas ligand causes leukocyte apoptosis.
Wang Y; Yi S; Tay YC; Feng X; Wang Y; Kairaitis L; Harris DC
Kidney Int; 2002 Apr; 61(4):1303-11. PubMed ID: 11918737
[TBL] [Abstract][Full Text] [Related]
22. Fas expression prevents cholangiocarcinoma tumor growth.
Pickens A; Pan G; McDonald JM; Vickers SM
J Gastrointest Surg; 1999; 3(4):374-81; discussion 382. PubMed ID: 10482689
[TBL] [Abstract][Full Text] [Related]
23. [Apoptosis of lymphocytes induced by Fas/FasL of colon cancer cells].
Zhu Q; Deng CS
Ai Zheng; 2002 Mar; 21(3):272-5. PubMed ID: 12451993
[TBL] [Abstract][Full Text] [Related]
24. Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells.
Ragnarsson GB; Mikaelsdottir EK; Vidarsson H; Jónasson JG; Olafsdóttir K; Kristjánsdóttir K; Kjartansson J; Ogmundsdóttir HM; Rafnar T
Br J Cancer; 2000 Dec; 83(12):1715-21. PubMed ID: 11104571
[TBL] [Abstract][Full Text] [Related]
25. Association between up-regulation of Fas ligand expression and apoptosis of tumor-infiltrating lymphocytes in human breast cancer.
Cheng B
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(5):573-5. PubMed ID: 17219972
[TBL] [Abstract][Full Text] [Related]
26. Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus.
Kauma SW; Huff TF; Hayes N; Nilkaeo A
J Clin Endocrinol Metab; 1999 Jun; 84(6):2188-94. PubMed ID: 10372730
[TBL] [Abstract][Full Text] [Related]
27. FasL expression in colorectal carcinoma and its significance in immune escape of cancer.
Tong Q; Liu K; Wang G
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(1):79-81. PubMed ID: 16711013
[TBL] [Abstract][Full Text] [Related]
28. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
29. Fas ligand expression in colon cancer: a possible mechanism of tumor immune privilege.
Zhang W; Ding EX; Wang Q; Zhu DQ; He J; Li YL; Wang YH
World J Gastroenterol; 2005 Jun; 11(23):3632-5. PubMed ID: 15962391
[TBL] [Abstract][Full Text] [Related]
30. Expression of fas ligand on bile ductule epithelium in biliary atresia--a poor prognostic factor.
Liu C; Chiu JH; Chin T; Wang LS; Li AF; Chow KC; Wei C
J Pediatr Surg; 2000 Nov; 35(11):1591-6. PubMed ID: 11083430
[TBL] [Abstract][Full Text] [Related]
31. Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas.
Shukuwa T; Katayama I; Koji T
Mod Pathol; 2002 Apr; 15(4):387-96. PubMed ID: 11950912
[TBL] [Abstract][Full Text] [Related]
32. Human colon cancer cells express the functional Fas ligand.
Ding EX; Hizuta A; Morimoto Y; Tanida T; Hongo T; Ishii T; Yamano T; Fujiwara T; Iwagaki H; Tanaka N
Res Commun Mol Pathol Pharmacol; 1998 Jul; 101(1):13-24. PubMed ID: 9755840
[TBL] [Abstract][Full Text] [Related]
33. Fas ligand expression in thyroid carcinomas: a potential mechanism of immune evasion.
Mitsiades N; Poulaki V; Mastorakos G; Tseleni-Balafouta ST; Kotoula V; Koutras DA; Tsokos M
J Clin Endocrinol Metab; 1999 Aug; 84(8):2924-32. PubMed ID: 10443700
[TBL] [Abstract][Full Text] [Related]
34. Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis.
Okada K; Komuta K; Hashimoto S; Matsuzaki S; Kanematsu T; Koji T
Clin Cancer Res; 2000 Sep; 6(9):3560-4. PubMed ID: 10999744
[TBL] [Abstract][Full Text] [Related]
35. Functional investigation of Fas ligand expressions in human non-small cell lung cancer cells and its clinical implications.
Lin Y; Liu L; Zhang T; Liu J
Ann Thorac Surg; 2013 Feb; 95(2):412-8. PubMed ID: 23021303
[TBL] [Abstract][Full Text] [Related]
36. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
37. Fas-related apoptosis in gastric adenocarcinoma.
Lim SC
Oncol Rep; 2003; 10(1):57-63. PubMed ID: 12469145
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus expressing p27KIP1 induces apoptosis against cholangiocarcinoma cells by triggering Fas ligand on the cell surface.
Yamamoto K; Katayose Y; Suzuki M; Unno M; Sasaki T; Mizuma M; Shiraso S; Ohtuka H; Cowan KH; Seth P; Matsuno S
Hepatogastroenterology; 2003; 50(54):1847-53. PubMed ID: 14696417
[TBL] [Abstract][Full Text] [Related]
39. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
Kim JW; Wieckowski E; Taylor DD; Reichert TE; Watkins S; Whiteside TL
Clin Cancer Res; 2005 Feb; 11(3):1010-20. PubMed ID: 15709166
[TBL] [Abstract][Full Text] [Related]
40. Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells.
Bamberger AM; Schulte HM; Thuneke I; Erdmann I; Bamberger CM; ASA SL
J Clin Endocrinol Metab; 1997 Sep; 82(9):3173-5. PubMed ID: 9284765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
